Drawing for CSL BIOTHERAPIES

USPTO serial 79027683

CSL BIOTHERAPIES

Reviewed by CopyMark Law Group

Reg. 3409295Status 404
Filing date
Status date
Registration date
Apr 8, 2008
Examiner
DELANEY, ZHALEH SYBIL
Law office
POST REGISTRATION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CSL BIOTHERAPIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Donald S. Gardner

Donald S. Gardner Gardner, Linn, Burkhart & Flory, LLP2851 Charlevoix Drive, S.E.Suite 207Grand Rapids, MI 49546

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment and/or prevention of blood or bleeding disorders; vaccines; blood plasma; products derived from blood, and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders; blood proteins for therapeutic use; in vitro diagnostic reagent test kits for use in detecting cell mediated immune responseSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 3, 2017DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Mar 3, 2017DETHDEATH OF INTERNATIONAL REGISTRATION—
Sep 11, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Aug 24, 2015INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 24, 2015INPCINVALIDATION PROCESSED—
Jul 26, 2015INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Nov 26, 2014C71TCANCELLED SECTION 71—
Dec 22, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 20, 2011TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 25, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 25, 2008FIMPFINAL DISPOSITION PROCESSED—
Jul 8, 2008FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 8, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 21, 2008OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 6, 2008OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 6, 2008OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 22, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 2, 2008NPUBNOTICE OF PUBLICATION—
Dec 17, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 12, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 12, 2007XAECEXAMINER'S AMENDMENT ENTERED—
Dec 12, 2007GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 12, 2007GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 12, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 4, 2007GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 4, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 4, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 2007ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Aug 30, 2007DOCKASSIGNED TO EXAMINER—
Aug 7, 2007PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
May 23, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 22, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 16, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
May 16, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 16, 2007ALIEASSIGNED TO LIE—
Apr 23, 2007MAILPAPER RECEIVED—
Feb 27, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 27, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 27, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 8, 2006RFNTREFUSAL PROCESSED BY IB—
Nov 22, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 22, 2006RFRRREFUSAL PROCESSED BY MPU—
Nov 21, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 20, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 16, 2006DOCKASSIGNED TO EXAMINER—
Oct 6, 2006NWAPNEW APPLICATION ENTERED—
Oct 5, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance